利用尿激酶静脉溶栓治疗是治疗急性脑梗死(6h以内)的一种有效办法。但对于超过溶栓时间窗以及不适合溶栓治疗的脑梗死患者,如何有效的阳止病情进展,降低致残率是脑梗死治疗的主要目标。我科自2006年3月至2007年3月对51例脑梗死患者给予纤溶酶与奥扎格雷联合治疗,并与同期单独应用纤溶酶治疗48例脑梗死患者进行对比观察,以评价其临床疗效和对血液流变学的影响。 Intravenous thrombolytic therapy with urokinase is an effective treatment for acute cerebral infarction (within 6h). However, for patients with cerebral infarction who are beyond the thrombolytic time window and not suitable for thrombolytic therapy, how to effectively improve the morbidity and reduce the morbidity is the main goal of treatment of cerebral infarction. Our department from March 2006 to March 2007 of 51 cases of cerebral infarction patients given plasminogen and ozagrel combination therapy, and with the same period alone fibrinolytic treatment of 48 patients with cerebral infarction compared to observe its Clinical Efficacy and Effects on Hemorheology.